Exosomes are secreted by cells and are widely present in body fluids. Exosomes contain various molecular constituents of their cells of origin such as proteins, mRNA, miRNAs, DNA, lipid and glycans which are very similar as the content in tumor cells. These contents play an important role in various stages of tumor development, and make the tumor-derived exosome as a hot and emerging biomarker for various cancers diagnosis and management in non-invasive manner. The present problems of exosome isolation and detection hinder the application of exosomes. With the development of exosome isolation and detection technology, the contents of exosomes can be exploited for early cancer diagnosis. This review summarizes the recent progress on exosomeassociated tumor biomarkers and some new technologies for exosome isolation and detection. Furthermore, we have also discussed the future development direction in exosome analysis methods. Development on exosome tumor markers Extracellular vesicle (EV) includes exosomes, microvesicles and apoptotic bodies. These vesicles have different size and biogenesis. Exosomes are complex 20-100 nm vesicles and generate in a way that intracellular multivesicular bodies (MVBs) containing intraluminal vesicles (ILVs) fuse with the plasma membrane [1]. Larger vesicles, microvesicles (100 nm-1 μm) and apoptotic bodies (1-5 μm), are released directly from the budding and fission of the plasma membrane [2]. In the past decades, researchers have become increasingly interested in the role of EVs, especially exosomes, in diseases. Exosomes contain various molecular constituents of their cell of origin such as proteins, RNAs, DNA, lipid glycans. Therefore, tumor-derived exosomes could tell the physiological and pathological states of parent tumor cells, and emerged to be a hot cancer biomarker in liquid biopsy field [3]. Given the rich molecular composition of exosomes and easy availability of liquid biopsy sample, many researchers [4] are pursuing to develop non-invasive diagnostic methods with higher sensitivity and specificity based on exosome, which has very high potential to help early diagnosis, treatment evaluation, and prognostic analysis of the disease. In this section, we have summarized the application of exosomes in tumor diagnosis based on its amount and molecular compositions. Level of exosomes in tumor diagnosis Studies show that the level of exosomes in plasma was significantly higher in cancers (such as ovarian cancer [5] and non-small-cell-lung cancer [6]) patients than that of healthy controls [7]. Therefore, many researchers hypothesize that levels of exosome in bodily fluid can serve as a potential diagnostic biomarker in cancer patients. Logozzi et al. [8] investigated the amount of